UK meningitis mutation fueling deadly outbreak in Kent as deaths rise
A mutated form of a lethal Group B Streptococcus (menB) strain is driving an unusually rapid spread across the county, resulting in 29 confirmed cases and two fatalities. Health officials have completed genetic analysis confirming that this specific variant has evolved to become more infectious than previous versions despite protection from standard vaccines like Bexsero.
Key Points
-
1A deadly meningitis B outbreak in Kent is causing a 'very unusual' rapid spread with rising case numbers.
-
2Health officials have completed an initial genetic analysis confirming the strain has mutated and may be more infectious than previous versions of Meningitis B.
-
3The UK Health Security Agency (UKHSA) warns that while this mutation aids transmission, it does not necessarily mean existing vaccines like Bexsero are ineffective.
-
4Secondary cases from individuals who did not attend the initial nightclub event remain a possibility as investigations continue.
Developments
Health officials have completed an initial genetic analysis confirming that meningitis cases in Kent are caused by group B bacteria, specifically sequence type 485 belonging to the larger complex of strains circulating since at least 2010. While this is not a new variant but rather appears as a newly identified subvariant within existing UK-borne clonal complexes ST-41/44 and similar ones from five years ago, two people have died so far with nearly thirty total cases reported to date.
A deadly Meningitidis group B outbreak in Kent has resulted in 29 cases and two deaths due to an unusually rapid spread that scientists are investigating for potential bacterial evolution or behavioral factors. While the available vaccine, Bexsero, protects against this specific strain, a victim's family is advocating for its expanded use among teenagers and young adults beyond current childhood immunization protocols.
UK Health Security officials confirmed via genetic analysis that 29 linked meningitis B cases in Kent involve sequence type ST-41/485 of group B bacteria. This strain is an existing variant, and while experts suggest a peak may have passed due to the incubation period's uncertainty regarding secondary transmission remains possible given its two-to ten-day range
Health officials warn a potentially mutated meningitis B strain may be driving an unusually rapid outbreak in Kent with 29 new confirmed cases. Scientists are using genome sequencing on patient samples to identify specific bacterial variants and determine if the bacteria has evolved increased transmissibility or virulence, though experts confirm that vaccines like Bexsero should still offer protection against menB strains identified so far.
Scientists are urgently investigating a deadly meningitis B strain linked to 27 cases, including two deaths and nine confirmed infections. Experts suspect it may have evolved increased transmissibility through genetic mutations but emphasize that firm conclusions regarding its enhanced spreadability remain unreached while vaccination efforts continue at the University of Kent in Canterbury.